The problem of clinical activity of long-acting neuroleptics.
作者信息
Smulevitch A B, Minsker E I, Mazayeva N A, Volkova R P, Lukanina S K
出版信息
Compr Psychiatry. 1973 May-Jun;14(3):227-33. doi: 10.1016/s0010-440x(73)80015-x.
PMID:4710310
Abstract
摘要
相似文献
1
The problem of clinical activity of long-acting neuroleptics.
Compr Psychiatry. 1973 May-Jun;14(3):227-33. doi: 10.1016/s0010-440x(73)80015-x.
2
[Importance of delayed-action neuroleptics].
Ann Med Psychol (Paris). 1969 May;127(5):772-8.
3
[Importance of delayed-action neuroleptics].
Ann Med Psychol (Paris). 1969 May;1(5):772-8.
4
[Use of new drug treatments in child psychiatry (long-acting neuroleptics, antidepressive agents and lithium)].
Cah Med. 1973 Sep 15;14(9):711-6.
5
[Importance of delayed-action compounds for management of neuroleptic treatments. (Apropos of fluphenazine enanthate)].
Presse Med (1893). 1967 May 20;75(24):1243-6.
6
[Long-acting neuroleptic preparations and their use in mental disorders].
Zh Nevropatol Psikhiatr Im S S Korsakova. 1972;72(6):920-4.
7
Clinical experience with depot neuroleptics.
Acta Psychiatr Scand Suppl. 1973;246:32-4. doi: 10.1111/j.1600-0447.1973.tb08446.x.
8
Differential study of 2 long-acting neuroleptics, fluphenazine enanthate and pipothiazine undecylenate.
Therapie. 1973 May-Jun;28(3):611-25.
9
The depot compounds moditen (fluphenazine) and IMAP (fluspirilene) in clinical practice.
Act Nerv Super (Praha). 1974 Aug;16(3):167-8.
10
[Trial of delayed-action neuroleptics in the treatment of acute psychotic conditions].
Ann Med Psychol (Paris). 1972 Mar;1(3):381-94.
引用本文的文献
1
Kinetics of fluphenazine after fluphenazine dihydrochloride, enanthate and decanoate administration to man.
Br J Clin Pharmacol. 1979 Apr;7(4):325-31. doi: 10.1111/j.1365-2125.1979.tb00941.x.
Zotero 插件